On September 1, 2020, the National Academies of Sciences, Engineering, and Medicine invited public comment on the Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, commissioned by the Centers for Disease Control and the National Institutes of Health. Input from the public, especially communities disproportionately affected by the COVID-19 pandemic, is essential to produce a final report that is objective, balanced, and inclusive. The public comment period was open for 4 days, from 12:00 p.m. ET on Tuesday, September 1, until 11:59 p.m. ET on Friday, September 4.
In addition, the study committee hosted a listening session on Wednesday, September 2, from 12:00 to 5:00 p.m. ET to hear comments from the public. For more information, please visit the study webpage. If you have any questions, please email COVIDVaccineFramework@nas.edu.
Table of Contents
|A Note from the Committee Co-Chairs||3-4|
|Lessons Learned from Other Allocation Efforts||5-30|
|A Framework for Equitable Allocation of COVID-19 Vaccine||31-87|
|Applying the Framework for Equitable Allocation of COVID-19 Vaccine in Various Scenarios||88-99|
|Committee on Equitable Allocation of Vaccine for the Novel Coronavirus||100-101|
|Appendix A: Committee Biosketches||103-111|
|Appendix B: Staff Biosketches||112-114|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine...